Centerspace vs NexPoint Residential Trust
CSR and NXRT side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CSR and NXRT compare
Centerspace is the larger company, worth 2.4 times as much as NexPoint Residential Trust ($956M against $396M).
NexPoint Residential Trust grew revenue faster over the last twelve months (0.68% versus −6.0% for Centerspace).
Centerspace keeps more of each dollar of sales as profit, with a net margin of 35.4% compared with −14.6% at NexPoint Residential Trust.
Both pay dividends: Centerspace yields 5.4% and NexPoint Residential Trust 13.7%.
Centerspace scores higher on the StockData Score (16 against 8 for NexPoint Residential Trust), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CSR | NXRT |
|---|---|---|
| Size and price | ||
| Market cap | $956M | $396M |
| Share price | $56.94 | $15.49 |
| Change, 1 year | −14.7% | −50.8% |
| Change, 5 years | −43.8% | −79.8% |
| Beta (5Y) | 0.68 | 0.90 |
| Employees | 349 | 3 |
| StockData Score | ||
| Total score | 16 (better) | 8 |
| Valuation score | 5 (better) | 3 |
| Growth score | 2 (better) | 1 |
| Performance score | 5 (better) | 0 |
| Health score | 0 | 0 |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 10.7× | – |
| P/S | 3.7× | 1.6× (better) |
| P/B | 1.2× (better) | 1.8× |
| EV/EBITDA | 3.9× | 3.1× (better) |
| Fair value | $129.09 | $32.45 |
| Margin of safety | 55.9% (better) | 52.3% |
| Growth | ||
| Revenue growth (TTM) | −6.0% | 0.68% (better) |
| Revenue growth, 5Y average | 9.0% (better) | 4.2% |
| Net income growth (TTM) | 199% | – |
| EPS growth (TTM) | 198% | – |
| Profitability | ||
| Gross margin | 96.6% | – |
| Operating margin | 56.1% (better) | 10.6% |
| Net margin | 35.4% (better) | −14.6% |
| Return on equity | 11.8% (better) | −13.6% |
| Return on invested capital | 16.1% (better) | 8.2% |
| Financial health | ||
| Interest coverage | 3.5× (better) | 0.4× |
| Altman Z-score | 0.62 (better) | 0.19 |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 5.4% | 13.7% (better) |
| Payout ratio | 56.7% | – |
| Years of dividend growth | 2 | 3 (better) |
| Dividend growth, 5Y average | 1.9% | – |
| Shareholder yield | 5.4% | 13.7% (better) |
| Ownership | ||
| Held by institutions | 94.1% | 81.5% |
| Held by insiders | 0.67% | 17.2% |
| Insider net buying, 12 months | $121K (better) | −$412K |
| Short interest, % of float | 4.8% | 8.2% |
Go deeper
- CSR stock overview
- CSR income statement
- CSR valuation and score
- NXRT stock overview
- NXRT income statement
- NXRT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.